Enfiera (Rituximab) Injection: Product Information
Description
Prescription-only medicine. For use under the supervision of a qualified healthcare professional. This page is for information and does not replace medical advice.
Overview
Enfiera Injection contains rituximab, a monoclonal antibody that targets the CD20 protein found on certain B lymphocytes (a type of white blood cell). By reducing these cells, it can help control some blood cancers and autoimmune diseases. It is given as an intravenous infusion in a hospital or clinic, never for self-administration.
Available strengths
Presentation Typical pack
Enfiera 100 mg 10 mL single-dose vial
Enfiera 500 mg 50 mL single-dose vial
Pack details, manufacturer and labelling can differ by batch and market. Always check the vial label, package insert and batch details before use.
Conditions it may be used for
A specialist may prescribe rituximab, depending on the approved indication and the patient’s situation, for:
Non-Hodgkin lymphoma, often alongside other treatments
Chronic lymphocytic leukaemia (CLL), as part of a specialist-directed plan
Rheumatoid arthritis, in eligible adults when other treatments have not worked well enough
Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), which are inflammatory conditions of the blood vessels
Results vary with the condition, its severity, any combination therapy and each patient’s response. Rituximab is not suitable for everyone.
Is it chemotherapy?
No. Rituximab is a targeted biological therapy, not a conventional cytotoxic chemotherapy drug. It is sometimes combined with chemotherapy in certain cancer regimens.
Important safety information
Rituximab can cause serious side effects, so patients are monitored closely.
Infusion-related reactions: fever, chills, rash, breathing difficulty or low blood pressure can occur, usually during or soon after the infusion. Pre-medication and monitoring are standard.
Infections: rituximab lowers B-cell levels and may raise infection risk.
Hepatitis B reactivation: patients are normally screened before treatment.
Rare serious events: these include severe skin or mouth reactions and a rare brain infection called PML.
Common effects: fatigue, headache, nausea and fever.
Tell your doctor before treatment about current or past infections (especially hepatitis B), other medical conditions, planned vaccinations, pregnancy or breastfeeding, and all medicines you take. Do not change a dose or schedule without medical advice.
Storage and handling
Store refrigerated at 2–8°C in the original carton, protected from light.
Do not freeze or shake the vial.
Maintain an unbroken cold chain from storage through transport to administration.
Follow the approved package insert for dilution and handling.
Frequently asked questions
What is Enfiera Injection used for?
It contains rituximab and is prescribed for certain blood cancers and autoimmune conditions, according to its approved indications.
Can it be given at home?
No. It must be given by intravenous infusion by trained professionals, because reactions can occur.
Is a prescription required?
Yes. It should be used only on the advice of a qualified specialist.
How is it stored?
Refrigerated at 2–8°C and never frozen, as per the product label.
Does the product pack differ between markets?
It can. Check the label, batch number and package insert for the product you have.
Enquiries for licensed healthcare businesses
Cordium Pharmaceuticals Pvt Ltd is a registered pharmaceutical supplier based in Nagpur, India. We respond to enquiries from licensed hospitals, pharmacies, clinics and distributors that hold the import authorisation required in their country. We do not supply prohibited or controlled medicines, and all supply is subject to the laws of the destination country.
To enquire, share your organisation name, licence details and country using the contact form or email [info@cordiumpharma.com].
Regulatory information: Drug licence no. MH-NG2-544742/MH-NG2-544743 | Export licence/IEC AALCC8570D | Registered address: Shiv Nagar, Plot No. 111, Godhani Road, Zingabai Takli, Nagpur 440030, India
